Company Analysis Sinocelltech Group Limited
1. Summary
Advantages
- The stock's return over the last year (37.23%) is higher than the sector average (-6.38%).
Disadvantages
- Price (45.33 Β₯) is higher than fair price (3.4 Β₯)
- Dividends (0%) are below the sector average (1.18%).
- Current debt level 59.79% has increased over 5 years from 41.71%.
- The company's current efficiency (ROE=-48.83%) is lower than the sector average (ROE=3.09%)
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| Sinocelltech Group Limited | Healthcare | Index | |
|---|---|---|---|
| 7 days | -5.4% | 0% | -1.5% |
| 90 days | 18.8% | -15.3% | -0.7% |
| 1 year | 37.2% | -6.4% | 30.5% |
688520 vs Sector: Sinocelltech Group Limited has outperformed the "Healthcare" sector by 43.62% over the past year.
688520 vs Market: Sinocelltech Group Limited has outperformed the market by 6.72% over the past year.
Stable price: 688520 is not significantly more volatile than the rest of the market on "Shanghai Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.
Long period: 688520 with weekly volatility of 0.716% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (45.33 Β₯) is higher than the fair price (3.4 Β₯).
Price is higher than fair: The current price (45.33 Β₯) is 92.5% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (149.05) is higher than that of the sector as a whole (55.1).
P/E vs Market: The company's P/E (149.05) is higher than that of the market as a whole (68.38).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (123.66) is higher than that of the sector as a whole (5.8).
P/BV vs Market: The company's P/BV (123.66) is higher than that of the market as a whole (2.83).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (6.64) is lower than that of the sector as a whole (19.87).
P/S vs Market: The company's P/S indicator (6.64) is higher than that of the market as a whole (6.29).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (-63.24) is lower than that of the sector as a whole (16.62).
EV/Ebitda vs Market: The company's EV/Ebitda (-63.24) is lower than that of the market as a whole (17.31).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -23.14% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-23.14%).
Profitability vs Sector: The return for the last year (0%) is lower than the return for the sector (3.16%).
5.4. ROE
ROE vs Sector: The company's ROE (-48.83%) is lower than that of the sector as a whole (3.09%).
ROE vs Market: The company's ROE (-48.83%) is lower than that of the market as a whole (7.83%).
5.5. ROA
ROA vs Sector: The company's ROA (3.73%) is higher than that of the sector as a whole (3.55%).
ROA vs Market: The company's ROA (3.73%) is higher than that of the market as a whole (3.28%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (0%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (0%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '1.18%.
7.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (94.76%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
